test

Raymond Debbane

@Siren, L.l.c.

Latest period2024 - Q3ReportedManaged Assets$2BTotal holdings110
Assets growth rate0%Assets growth rate (2-Q avg)0%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Siren, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Siren, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2B in assets, with a quarterly growth rate of 0% and a 2-quarter average growth rate of 0%. The portfolio is managed by Raymond Debbane, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RVMDRevolution Medicines Inc
Recent Activity
New Position
1.71%
$34.176M
753,601 shares@ $45.35 avg price
MRUSMerus Nv
Recent Activity
New Position
1.71%
$34.083M
682,201 shares@ $49.97 avg price
TBLATaboola.com Ltd
Recent Activity
New Position
1.68%
$33.498M
9.969M shares@ $3.36 avg price
LBPHLongboard Pharmaceuticals Inc
Recent Activity
New Position
1.51%
$30.105M
903,227 shares@ $33.34 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
New Position
1.47%
$29.282M
743,769 shares@ $39.38 avg price
CYTKCytokinetics Inc
Recent Activity
New Position
1.39%
$27.771M
525,971 shares@ $52.81 avg price
KURAKura Oncology Inc
Recent Activity
New Position
1.31%
$26.182M
1.34M shares@ $19.55 avg price
RCUSArcus Biosciences Inc
Recent Activity
New Position
1.24%
$24.649M
1.612M shares@ $15.29 avg price
DNLIDenali Therapeutics Inc
Recent Activity
New Position
1.22%
$24.295M
834,028 shares@ $29.14 avg price
ERASErasca Inc
Recent Activity
New Position
1.21%
$24.18M
8.857M shares@ $2.74 avg price